MedTrace Logo

MonoPlus® in Orthopedic Surgery

NCT05257278 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2024-09-19

No results posted yet for this study

Summary

Single-center postmarket clinical follow-up study (PMCF) on the performance and safety of MonoPlus® in patients undergoing orthopedic surgery

Conditions

  • Orthopedic Surgery
  • Soft Tissue Approximation

Interventions

DEVICE

MonoPlus®

MonoPlus® is indicated for use in general soft tissue approximation, specially in cases where extended wound support of more than 4 weeks is desirable

Sponsors & Collaborators

  • B.Braun Surgical SA

    collaborator INDUSTRY

  • Aesculap AG

    lead INDUSTRY

Principal Investigators

  • Pablo Sanz Ruiz · Gregorio Marañón Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-18
Primary Completion
2023-07-07
Completion
2024-07-07

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05257278 on ClinicalTrials.gov